Post-COVID-19 SyndromeYoFaPoCoNCT05890599
Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome
A study testing Yoga Therapy and Health Education in people with Post-COVID-19 Syndrome and Fatigue Post Viral, run by University Hospital Tuebingen at 1 site in Germany.
Trial summary
Evaluation of the short- and medium-term effect of a yoga intervention in addition to routine care compared to health education in addition to routine care on fatigue in patients with post covid syndrome. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Post-COVID-19 Syndrome, Fatigue Post Viral
- What is being tested?
- Yoga Therapy and Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteGermany
- Study dates
- 10 Jun 2023to 31 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Confirmed COVID-19 diagnosis
- Follow-up symptoms of ≥ 12 weeks
- Persistent fatigue (scores ≥4 on the binomial Chalder Fatigue Scale).
- Self-assessment that fatigue was a consequence of COVID-19 disease
- Age 18-65 years
Who cannot join
- Chronic medical conditions or regular use of medications associated with fatigue
- Indication of health cause of fatigue other than post-COVID.
- Indication of other factors as the main cause of fatigue
- Physical limitations that do not allow participation in the yoga intervention
- Pregnancy, breastfeeding
- Concurrent participation in other clinical trials
- Current yoga practice
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Randomized Multicenter Clinical Trial: Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome
Evaluation of the short- and medium-term effect of a yoga intervention in addition to routine care compared to health education in addition to routine care on fatigue in patients with post covid syndrome.
- Conditions
- Post-COVID-19 Syndrome, Fatigue Post Viral
- Being tested
- Yoga Therapy, Health Education
- Keywords
- Fatigue, Covid
- Medical subject headings
- Post-Acute COVID-19 Syndrome, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Yoga TherapyBehavioural
The range of interventions is based on previous studies on yoga interventions specifically for fatigue patients as well as on recommendations, for example, from the WHO. The yoga therapy includes 3 elements: yoga postures (asanas), breathing techniques (pranayama) and relaxation moments.
Emphasis on postures and breathing techniques that are considered to be effective for fatigue symptoms, as well as specific breathing exercises to strengthen the respiratory muscles and increase lung volume.
Health EducationBehavioural
Health education courses are conducted on-site once a week for 90 minutes over a 12-week period by a psychologist with clinical experience. The courses are didactic in nature and consist of lectures on topics of interest to patients with post-COVID syndrome and fatigue, followed by questions and discussion sessions. Topics include information on post-COVID syndrome and fatigue, an introduction to self-help for post-viral symptoms, psychosocial problems and fatigue, relaxation and stress management, nutrition, sleep hygiene, exercise, respecting one's own limits, acceptance, finding meaning, and achieving goals.
| Study group | Role | What they receive |
|---|---|---|
| Yoga Therapy | Experimental | 12 week yoga program, one weekly session of 90 minutes each, plus 2 times weekly 30 minutes of self practice. Receives: Behavioral: Yoga Therapy |
| Health Education | Active comparator | 12 week health education program, one weekly session of 90 minutes each, plus 2 times weekly 30 minutes of self practice. Receives: Behavioral: Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fatigue
The chalder fatigue scale is used to assess the severity of fatigue within the last 4 weeks. It contains 11 questions in a four-step answer format (0-4), 7 of which refer to the degree of physical fatigue and 4 to the degree of mental fatigue. In its binomial evaluation (range 0-11) it can be used with a cut-off of (≥ 4) to divide patients into those with and those without fatigue.
Measured: 12 weeks
Secondary outcomes (35)
Fatigue
The chalder fatigue scale is used to assess the severity of fatigue within the last 4 weeks. It contains 11 questions in a four-step answer format (0-4), 7 of which refer to the degree of physical fatigue and 4 to the degree of mental fatigue. In its binomial evaluation (range 0-11) it can be used with a cut-off of (≥ 4) to divide patients into those with and those without fatigue.
Measured: 24 weeks
Health related quality of life SF-12
Short Form 12 Health Survey Questionnaire, The SF-12 represents the most commonly used instrument in clinical trials to assess generic quality of life. The questionnaire captures 8 different subscales, which are combined into a physical and a psychological summated scale.
Measured: 12 weeks
Health related quality of life SF-12
Short Form 12 Health Survey Questionnaire, The SF-12 represents the most commonly used instrument in clinical trials to assess generic quality of life. The questionnaire captures 8 different subscales, which are combined into a physical and a psychological summated scale.
Measured: 24 weeks
Health related quality of life EQ-5D-5L
The EQ-5D-5L is a self-assessed, health related, quality of life questionnaire. The scale measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. In this study, the EQ-5D-5L is used for cost-effectiveness analysis, together with healthcare-related costs.
Measured: 12 weeks
Health related quality of life EQ-5D-5L
The EQ-5D-5L is a self-assessed, health related, quality of life questionnaire. The scale measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. In this study, the EQ-5D-5L is used for cost-effectiveness analysis, together with healthcare-related costs.
Measured: 24 weeks
Psychological symptoms
The Hospital Anxiety and Depression Scale asks 14 questions, of which 7 are about anxiety and 7 about depression in patients with physical illnesses and physical complaints. More precisely, it measures the self-assessed severity of patients' anxious and depressive symptoms in relation to the past week.
Measured: 12 weeks
Psychological symptoms
The Hospital Anxiety and Depression Scale asks 14 questions, of which 7 are about anxiety and 7 about depression in patients with physical illnesses and physical complaints. More precisely, it measures the self-assessed severity of patients' anxious and depressive symptoms in relation to the past week.
Measured: 24 weeks
Sleep quality
The Pittsburgh Sleep Quality Index (PSQI) assesses the quality of sleep over the past 4 weeks using 24 questions, 17 for self-assessment and 7 for external assessment. It is used clinically to monitor patients with sleep disorders and to screen for sleep disorders in epidemiological studies. In this study, only the 17 self-assessment items are collected.
Measured: 12 weeks
Sleep quality
The Pittsburgh Sleep Quality Index (PSQI) assesses the quality of sleep over the past 4 weeks using 24 questions, 17 for self-assessment and 7 for external assessment. It is used clinically to monitor patients with sleep disorders and to screen for sleep disorders in epidemiological studies. In this study, only the 17 self-assessment items are collected.
Measured: 24 weeks
Stress
The current stress perception of the patients is assessed by means of the Perceived Stress Scale (PSS-10). This measures the current subjective perceived stress of the patients on the basis of 10 items.
Measured: 12 weeks
Stress
The current stress perception of the patients is assessed by means of the Perceived Stress Scale (PSS-10). This measures the current subjective perceived stress of the patients on the basis of 10 items.
Measured: 24 weeks
Post-exertional malaise
Post-exertional malaise (PEM) is a delayed worsening of symptoms that occurs after minimal physical or mental activity. The DePaul-Symptom Questionaire (DSQ) is used to asses PEM.
Measured: 12 weeks
Post-exertional malaise
Post-exertional malaise (PEM) is a delayed worsening of symptoms that occurs after minimal physical or mental activity. The DePaul-Symptom Questionaire (DSQ) is used to asses PEM.
Measured: 24 weeks
Body awareness
The Body Awareness Questionnaire (BAQ) assesses participants' subjective body awareness in four subdimensions: note responses or changes in body processes, predict bodily reaction, sleep-wake cycle, and onset of illness. The validated single-factor German version consists of 17 questions on a 7-point Likert scale from 1 (not at all true about me) to 7 (very true about me). The values of the individual items are added together to form a total score. Body awareness will be used in mediation analyses of treatment effects.
Measured: 12 weeks
Body awareness
The Body Awareness Questionnaire (BAQ) assesses participants' subjective body awareness in four subdimensions: note responses or changes in body processes, predict bodily reaction, sleep-wake cycle, and onset of illness. The validated single-factor German version consists of 17 questions on a 7-point Likert scale from 1 (not at all true about me) to 7 (very true about me). The values of the individual items are added together to form a total score. Body awareness will be used in mediation analyses of treatment effects.
Measured: 24 weeks
Self-Efficacy
The Arthritis Self-Efficacy Scale (ASES) was originally developed in 1989 as part of the Stanford Arthritis Self-Management Study to assess self-efficacy in arthritis patients and has since been used to assess it in many disease conditions. A short version (ASES-8/ASES-D) has been validated. This version surveys in scale level 1-10 the perceived ability to deal with occurring symptoms such as: Pain or fatigue. Self-efficacy will be used in mediation analyses of treatment effects.
Measured: 12 weeks
Self-Efficacy
The Arthritis Self-Efficacy Scale (ASES) was originally developed in 1989 as part of the Stanford Arthritis Self-Management Study to assess self-efficacy in arthritis patients and has since been used to assess it in many disease conditions. A short version (ASES-8/ASES-D) has been validated. This version surveys in scale level 1-10 the perceived ability to deal with occurring symptoms such as: Pain or fatigue. Self-efficacy will be used in mediation analyses of treatment effects.
Measured: 24 weeks
Adverse events
Adverse events and serious adverse events are documented. Adverse events include any adverse symptoms, illnesses, disorders, or accidents that occur during the course of the study. Serious adverse events include events occurring during the course of the study that are immediately life-threatening and/or result in serious health problems (specifically, requiring unanticipated hospitalization or prolongation of hospitalization, or resulting in serious disability or incapacitation). Adverse events (including PEM) and serious adverse events will be documented by participants on a weekly basis throughout the intervention period. Participants will be instructed to immediately notify the study site upon the occurrence of any serious adverse event. The severity as well as the possible causal relationship with the intervention will be assessed by the study physician.
Measured: Week 0, 1-12, 13 and 25
C-reactive proteine
CRP as marker of pro-inflammatory cytokine activity, from blood samples.
Measured: 12 weeks
C-reactive proteine
CRP as marker of pro-inflammatory cytokine activity, from blood samples.
Measured: 24 weeks
Interleukine-6
IL-6, as marker of pro-inflammatory cytokine activity, from blood samples.
Measured: 12 weeks
Interleukine-6
IL-6, as marker of pro-inflammatory cytokine activity, from blood samples.
Measured: 24 weeks
D-dimer
D-dimer, as a by-product of the blood clotting and break-down process that can be measured via analysis of a blood sample
Measured: 12 weeks
D-dimer
D-dimer, as a by-product of the blood clotting and break-down process that can be measured via analysis of a blood sample
Measured: 24 weeks
Lactate dehydrogenase
Lactate dehydrogenase (LDH), measuring the amount of LDH in the blood. Lactate dehydrogenase is an enzyme that the body uses during the process of turning sugar into energy for your cells to use.
Measured: 12 weeks
Lactate dehydrogenase
Lactate dehydrogenase (LDH), measuring the amount of LDH in the blood. Lactate dehydrogenase is an enzyme that the body uses during the process of turning sugar into energy for your cells to use.
Measured: 24 weeks
Leukocytes and lymphocytes
Leukocytes and lymphocytes, from blood samples.
Measured: 12 weeks
Leukocytes and lymphocytes
Leukocytes and lymphocytes, from blood samples.
Measured: 24 weeks
Hand grip strength
Repeated measurement of hand strength can help detect physical decline and inflammatory processes Hand grip strength measurement can be an invaluable tool for monitoring physical performance decline.
Measured: 12 weeks
Hand grip strength
Repeated measurement of hand grip strength can help detect physical decline and inflammatory processes Hand strength measurement can be an invaluable tool for monitoring physical performance decline.
Measured: 24 weeks
Movement tracking
General tracking of patients' movement habits via activity monitor
Measured: 12 weeks
Movement tracking
General tracking of patients' movement habits via activity monitor
Measured: 24 weeks
Heart rate variability
24-hour measurement of heart rate variability (HRV) to determine the functionality of the participant's autonomic nervous system. A 3-channel ECG recorder (SRA/Multi-ECG recorder, SR-Medizinelektronik, Stuttgart, Germany) is used. Several HRV time-domain and HRV frequency-domain measures will be evaluated and analyzed for the total day and night (sleeping time) period as well as for 5-minutes-intervals within these two periods (SDNN, RMSSD, pNN50, SDANN, SDNNI, VLF power, LF power, HF power, LF/HF).
Measured: 12 weeks
Heart rate variability
24-hour measurement of heart rate variability (HRV) to determine the functionality of the participant's autonomic nervous system. A 3-channel ECG recorder (SRA/Multi-ECG recorder, SR-Medizinelektronik, Stuttgart, Germany) is used. Several HRV time-domain and HRV frequency-domain measures will be evaluated and analyzed for the total day and night (sleeping time) period as well as for 5-minutes-intervals within these two periods (SDNN, RMSSD, pNN50, SDANN, SDNNI, VLF power, LF power, HF power, LF/HF).
Measured: 24 weeks
Cost for Patient Questionnaire (CoPaQ)
Direct medical and non-medical costs are collected using this questionnaire. The questionnaire is a modified version of the Cost for Patient Questionnaire (CoPaQ), designed to collect all information on health care costs.
Measured: 12 weeks, 24 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jun 2023
- Study start10 Jun 2023
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Post-COVID-19 SyndromeStudies of the same condition, open and under way.
- More trials run by University Hospital TuebingenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital Tuebingen
- Sponsor type
- University, hospital or other
- Collaborators
- Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF), Charite University, Berlin, Germany
- Responsible party
- Sponsor
- Investigators
- Holger Cramer, Professor, Study director, University Hospital Tuebingen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05890599
- Sponsor's protocol ID
- S00766-RBK
- Acronym
- YoFaPoCo
- Status last verified
- Jul 2025
- First submitted
- 2 Jun 2023
- Last updated
- 10 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cramer H, Morchen L, Vagedes J, Klenk J, Jager S, Schleinzer A, Anheyer D, Bilc M, Schroter M, Kessler C, Jeitler M. Yoga versus health education for persistent fatigue in patients with post-COVID-19 syndrome: protocol for a multicentre randomised controlled trial. BMJ Open. 2025 Oct 23;15(10):e107840. doi: 10.1136/bmjopen-2025-107840.
PubMed 41130694
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Multicenter Clinical Trial: Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome
- ClinicalTrials.gov ID
- NCT05890599
- Acronym / sponsor ID
- YoFaPoCo / S00766-RBK
- Conditions
- Post-COVID-19 Syndrome, Fatigue Post Viral
- Keywords
- Fatigue, Covid
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University Hospital TuebingenUniversity, hospital or other
- Collaborators
- Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF), Charite University, Berlin, Germany
- Study start
- 10 Jun 2023 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Mar 2026 (estimated)
- First posted
- 6 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation of the short- and medium-term effect of a yoga intervention in addition to routine care compared to health education in addition to routine care on fatigue in patients with post covid syndrome.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Yoga Therapy | Experimental | Behavioral: Yoga Therapy12 week yoga program, one weekly session of 90 minutes each, plus 2 times weekly 30 minutes of self practice. |
| Health Education | Active comparator | Behavioral: Health Education12 week health education program, one weekly session of 90 minutes each, plus 2 times weekly 30 minutes of self practice. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Confirmed COVID-19 diagnosis
- Follow-up symptoms of ≥ 12 weeks
- Persistent fatigue (scores ≥4 on the binomial Chalder Fatigue Scale).
- Self-assessment that fatigue was a consequence of COVID-19 disease
- Age 18-65 years
Key exclusion criteria (7 listed)
- Chronic medical conditions or regular use of medications associated with fatigue
- Indication of health cause of fatigue other than post-COVID.
- Indication of other factors as the main cause of fatigue
- Physical limitations that do not allow participation in the yoga intervention
- Pregnancy, breastfeeding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Yoga TherapyThe range of interventions is based on previous studies on yoga interventions specifically for fatigue patients as well as on recommendations, for example, from the WHO. The yoga therapy includes 3 elements: yoga postures (asanas), breathing techniques (pranayama) and relaxation moments. Emphasis on postures and breathing techniques that are considered to be effective for fatigue symptoms, as well as specific breathing exercises to strengthen the respiratory muscles and increase lung volume. | Behavioural | Yoga Therapy |
| Health EducationHealth education courses are conducted on-site once a week for 90 minutes over a 12-week period by a psychologist with clinical experience. The courses are didactic in nature and consist of lectures on topics of interest to patients with post-COVID syndrome and fatigue, followed by questions and discussion sessions. Topics include information on post-COVID syndrome and fatigue, an introduction to self-help for post-viral symptoms, psychosocial problems and fatigue, relaxation and stress management, nutrition, sleep hygiene, exercise, respecting one's own limits, acceptance, finding meaning, and achieving goals. | Behavioural | Health Education |
Primary outcome
Fatigue
Time frame: 12 weeks
The chalder fatigue scale is used to assess the severity of fatigue within the last 4 weeks. It contains 11 questions in a four-step answer format (0-4), 7 of which refer to the degree of physical fatigue and 4 to the degree of mental fatigue. In its binomial evaluation (range 0-11) it can be used with a cut-off of (≥ 4) to divide patients into those with and those without fatigue.
35 secondary outcomes
Fatigue
Time frame: 24 weeks
Health related quality of life SF-12
Time frame: 12 weeks
Health related quality of life SF-12
Time frame: 24 weeks
Health related quality of life EQ-5D-5L
Time frame: 12 weeks
Health related quality of life EQ-5D-5L
Time frame: 24 weeks
Psychological symptoms
Time frame: 12 weeks
Psychological symptoms
Time frame: 24 weeks
Sleep quality
Time frame: 12 weeks
Sleep quality
Time frame: 24 weeks
Stress
Time frame: 12 weeks
Stress
Time frame: 24 weeks
Post-exertional malaise
Time frame: 12 weeks
Post-exertional malaise
Time frame: 24 weeks
Body awareness
Time frame: 12 weeks
Body awareness
Time frame: 24 weeks
Self-Efficacy
Time frame: 12 weeks
Self-Efficacy
Time frame: 24 weeks
Adverse events
Time frame: Week 0, 1-12, 13 and 25
C-reactive proteine
Time frame: 12 weeks
C-reactive proteine
Time frame: 24 weeks
Interleukine-6
Time frame: 12 weeks
Interleukine-6
Time frame: 24 weeks
D-dimer
Time frame: 12 weeks
D-dimer
Time frame: 24 weeks
Lactate dehydrogenase
Time frame: 12 weeks
Lactate dehydrogenase
Time frame: 24 weeks
Leukocytes and lymphocytes
Time frame: 12 weeks
Leukocytes and lymphocytes
Time frame: 24 weeks
Hand grip strength
Time frame: 12 weeks
Hand grip strength
Time frame: 24 weeks
Movement tracking
Time frame: 12 weeks
Movement tracking
Time frame: 24 weeks
Heart rate variability
Time frame: 12 weeks
Heart rate variability
Time frame: 24 weeks
Cost for Patient Questionnaire (CoPaQ)
Time frame: 12 weeks, 24 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2025.
- Derived from this study: PubMed 41130694Cramer H, Morchen L, Vagedes J, Klenk J, Jager S, Schleinzer A, Anheyer D, Bilc M, Schroter M, Kessler C, Jeitler M. Yoga versus health education for persistent fatigue in patients with post-COVID-19 syndrome: protocol for a multicentre randomised controlled trial. BMJ Open. 2025 Oct 23;15(10):e107840. doi: 10.1136/bmjopen-2025-107840.
- Individual participant dataSharing planned: No
Related trials for Post-COVID-19 Syndrome
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 3
The Study of Brave-LC LDN Treatment Trial
Post-acute COVID-19 Syndrome
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Enrolling by invitationPhase 2
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Systemic Inflammation, Neuroinflammation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Holger Cramer, Professor study director
University Hospital Tuebingen
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Yoga Therapy and Health Education in people with Post-COVID-19 Syndrome and Fatigue Post Viral, run by University Hospital Tuebingen at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Holger Cramer, Professor (+49 711 8101 7858, yasemin.anguelov@bosch-health-campus.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fatigue (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05890599, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.